Chill Brands Group (LSE:CHLL) Faces A New UK Cannabis Debate As NHS Access Returns To Focus
Highlights A new white paper calling for an nhs medical-cannabis pilot has renewed attention on access, evidence and the gap between wellness products and prescription medicine. The lead market theme is a fresh industry call for an NHS pilo…
Covered by 1 outlet
All coverage · 2 articles
Chill Brands (LSE:CHLL) Faces A New UK Cannabis Debate As NHS Access Returns To Focus
Highlights A new white paper calling for an nhs medical-cannabis pilot has renewed attention on access, evidence and the gap between wellness products and prescription medicine. The lead market theme is a fresh industry call for an NHS pilo…
Chill Brands Group (LSE:CHLL) Faces A New UK Cannabis Debate As NHS Access Returns To Focus
Highlights A new white paper calling for an nhs medical-cannabis pilot has renewed attention on access, evidence and the gap between wellness products and prescription medicine. The lead market theme is a fresh industry call for an NHS pilo…